Read review Dihexa for Migraine & Chronic Migraine The May 2024 NICE TA973 atogepant (Aquipta, AbbVie) approval, the rimegepant / erenumab / galcanezumab / fremanezumab / eptinezumab CGRP pathway, 2025 chronic-migraine hippocampal atrophy & accelerated brain ageing research, the Tanure BDNF-elevated-in-attack paradox, NICE NG150, and the ~10 million UK migraine population
70754-23-3 Source Synthetic Form Powder Description Phospho DSIP is also named: Delta (Phospho) Sleep Inducing Peptide, pDSIP
Supporting this hypothesis, we demonstrate that GLP-1 receptor-mediated targeting of MK-801 effectively avoids other adverse effects associated with MK-801 monotherapy, including hyperthermia and hyperlocomotion
Supplementation may support resilience during hormonal shifts, but always consult a clinician first
Since their safety, efficacy, and purity cannot be confirmed, we prescribe FDA-approved GLP-1s here at MyMenopauseRx
The induced eumelanin helps these patients tolerate light exposure